These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12571607)

  • 1. A cold shoulder for stocks.
    Smaglik P
    Nature; 2003 Feb; 421(6923):671. PubMed ID: 12571607
    [No Abstract]   [Full Text] [Related]  

  • 2. Taiwan: Biotech vision.
    Cyranoski D
    Nature; 2003 Feb; 421(6923):672-3. PubMed ID: 12571608
    [No Abstract]   [Full Text] [Related]  

  • 3. Stock options could no longer be the carrot.
    Lawrence S
    Nat Biotechnol; 2005 Feb; 23(2):157. PubMed ID: 15696132
    [No Abstract]   [Full Text] [Related]  

  • 4. Recruiters and industry. Dual competencies.
    Rousselle T
    Nature; 2004 Jul; 430(6998):488. PubMed ID: 15269780
    [No Abstract]   [Full Text] [Related]  

  • 5. Calling for entrepreneurs London.
    Smaglik P
    Nature; 2002 Sep; 419(6904):4-5. PubMed ID: 12239519
    [No Abstract]   [Full Text] [Related]  

  • 6. Is your biotech giving away the store?
    Jacobs T
    Nat Biotechnol; 2002 Nov; 20(11):1079. PubMed ID: 12410245
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech stocks struggle as financial markets tumble.
    Mitchell P
    Nat Biotechnol; 2002 Aug; 20(8):755-6. PubMed ID: 12147984
    [No Abstract]   [Full Text] [Related]  

  • 8. Taking a risk in start-ups.
    Gewin V
    Nature; 2004 May; 429(6990):484-5. PubMed ID: 15164077
    [No Abstract]   [Full Text] [Related]  

  • 9. Young scientist: Italian biotechnologists organize.
    Lescai F; Quarta M
    Nature; 2003 Oct; 425(6958):644. PubMed ID: 14534594
    [No Abstract]   [Full Text] [Related]  

  • 10. Science and commerce. Chemists for hire: have flask, will travel.
    Alper J
    Science; 2001 Aug; 293(5533):1249-51. PubMed ID: 11509708
    [No Abstract]   [Full Text] [Related]  

  • 11. Compensation continues rise.
    Lawrence S
    Nat Biotechnol; 2009 Jan; 27(1):14. PubMed ID: 19131985
    [No Abstract]   [Full Text] [Related]  

  • 12. Executive compensation at private biotech companies: beyond hearsay.
    Rychlik B; DiPierro M
    Nat Biotechnol; 2006 Dec; 24(12):1599-600. PubMed ID: 17160064
    [No Abstract]   [Full Text] [Related]  

  • 13. What are you worth?
    Yaroshevsky-Glanville M
    Nat Biotechnol; 2006 Apr; 24(4):469-70. PubMed ID: 16601734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing your compensation expectations in today's environment: a second look.
    Radford J
    Nat Biotechnol; 2004 Jul; 22(7):925-6. PubMed ID: 15229556
    [No Abstract]   [Full Text] [Related]  

  • 15. Executive compensation at private biotech companies: a competitive environment.
    Rychlik B; Dipierro M
    Nat Biotechnol; 2008 Jan; 26(1):133-4. PubMed ID: 18183026
    [No Abstract]   [Full Text] [Related]  

  • 16. AHA's profits take tumble.
    Reilly P
    Mod Healthc; 2002 Aug; 32(34):8-9, 16. PubMed ID: 12219592
    [No Abstract]   [Full Text] [Related]  

  • 17. US venture capital for biotechnology.
    Dibner MD; Trull M; Howell M
    Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144
    [No Abstract]   [Full Text] [Related]  

  • 18. Taking stock of biotech jobs.
    Smaglik P
    Nature; 2002 May; 417(6888):3. PubMed ID: 12037521
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech as an employer.
    Lawrence S
    Nat Biotechnol; 2007 Jan; 25(1):12. PubMed ID: 17211380
    [No Abstract]   [Full Text] [Related]  

  • 20. A youthful field.
    Smaglik P
    Nature; 2002 Oct; 419(6908):3. PubMed ID: 12384655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.